Biogen Inc. (BIIB) Presents at Evercore 8th Annual Healthcare Conference Transcript

Core Viewpoint - The company has undergone significant changes under the leadership of the new CEO, Chris Viehbacher, focusing on restructuring and cost-cutting measures to improve financial performance [2]. Group 1: Company Restructuring - The company has initiated a program called "Fit for Growth" aimed at restructuring cost allocations within the organization [2]. - The restructuring efforts are projected to achieve $1 billion in gross savings and $800 million in net savings [2].